In addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...

The addition of relacorilant to nab-paclitaxel significantly extended survival for women with platinum-resistant ovarian ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...

Gileads Trodelvy shows significant improvement in PFS in phase III ASCENT-03 trial for first-line metastatic TNBC, reinforcing potential as backbone therapy.

On World No Tobacco Day, Imperial Tobacco Canada (Imperial) is calling on government, health advocates, and all Canadians to embrace?harm reduction as a key strategy to achieve a smokeless Canada in ...

Octave Bioscience, Inc., a leading precision care company that is delivering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, announced the appointments of ...

Absolute Risk Reduction (ARR): the absolute difference in the percentage of patients who did not develop grade 4 neutropenia in the test group versus the control group.

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

The FDA granted approval to Merck's drug, Welireg, for its third indication in the United ... Teliso-V, which will be marketed by the name of Emrelis, is the first-in-class therapy approved for the ...

Prevail provides superior deliverability, an effective antirestenotic drug formulation (paclitaxel), and sustainable ... to give their patients best-in-class care.” ...

The FDA granted approval to Merck’s MRK drug, Welireg, for its third indication in the United ... Teliso-V, which will be marketed by the name of Emrelis, is the first-in-class therapy approved for ...